SPAdd image
SLU-PP-332
Weight LossSingleAn experimental small-molecule ERR agonist (estrogen-related receptor) studied in mice as a potential exercise mimetic with weight-loss effects.
Half-life
—
Common dose
100 – 500 mcg
Dosing frequency
Daily
Administration
Subcutaneous
How it works
SLU-PP-332 activates the ERRα/β/γ receptors involved in mitochondrial function and energy expenditure, producing exercise-adaptation-like changes in muscle and metabolism.
Protocol notes
No established human protocols. Preclinical mouse studies used 50 mg/kg daily.
Reported side effects
No human safety data. Highly experimental.